Reason: Rebranded as Lifecore Biomedical
Last recorded trade on: January 17, 2023
Source: https://ir.landec.com/news-releases/news-release-details/landec-corporation-announces-intention-become-lifecore
P/E ratio for Landec (LNDC)
P/E ratio on January 17, 2023 (TTM): -2.59
According to Landec's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.59375. At the end of 2021 the company had a P/E ratio of -5.81.
P/E ratio history for Landec from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -5.81 | -6.69% |
| 2020 | -6.23 | -79.83% |
| 2019 | -30.9 | -306.04% |
| 2018 | 15.0 | -62.56% |
| 2017 | 40.0 | -227.56% |
| 2016 | -31.4 | -225.74% |
| 2015 | 24.9 | 11.69% |
| 2014 | 22.3 | 22.55% |
| 2013 | 18.2 | 41.7% |
| 2012 | 12.9 | |
| 2003 | 659 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 5.69 | -319.35% | 🇺🇸 USA |
 | 8.83 | -440.39% | 🇺🇸 USA |
 | 26.1 | -1,104.87% | 🇺🇸 USA |
 | -735 | 28,219.34% | 🇺🇸 USA |
 | 13.7 | -628.03% | 🇺🇸 USA |
 | 12.6 | -585.78% | Cayman Islands |
 | 12.8 | -592.90% | 🇺🇸 USA |
 | 25.2 | -1,071.12% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.